What do you monitor with amiodarone?

What do you monitor with amiodarone?

Patients should be reviewed 6 monthly by their GP and monitored carefully for adverse effects of amiodarone therapy, particularly pulmonary toxicity and arrhythmias. U&E, TFT & LFT should also be monitored 6 monthly.

What are the hemodynamic parameters?

The primary hemodynamic parameters include heart rate (HR) and blood pressure (BP), while the advanced hemodynamic parameters include stroke volume (SV), cardiac output (CO), and total peripheral resistance (TPR) [14].

Does amiodarone increase stroke volume?

Stroke volume increased by 18% (p = 0.005). There was no significant correlation between the change in LVEF and the pre-amiodarone LVEF, the time interval between studies, or with indexes of amiodarone effect (change in heart rate, QRS, QTc, TSH, amiodarone dosage).

What is the drug monitoring guideline for amiodarone?

AMIODARONE DRUG MONITORING GUIDELINE This SCP has been written to enable the safe and appropriate continuation of care for patients initiated on amiodarone in hospital. Amiodarone is always started in secondary care.

Is the Vigileo hemodynamic monitor still available?

The Vigileo hemodynamic monitor is no longer commercially available and service and support has been discontinued. In an effort to advance your patient monitoring, we are offering generous trade-in incentives for upgrading your Vigileo monitor to the Edwards EV1000 clinical platform.

How is amiodarone used in the treatment of atrial fibrillation?

Am Fam Physician. 2003 Dec 1;68(11):2189-2197. Amiodarone is a potent antiarrhythmic agent that is used to treat ventricular arrhythmias and atrial fibrillation. The drug prevents the recurrence of life-threatening ventricular arrhythmias and produces a modest reduction of sudden deaths in high-risk…

How often should I take amiodarone for arrhythmia?

The loading dose should be prescribed by secondary care and GPs only asked to prescribe amiodarone at the maintenance dose. Maintenance usually 200mg daily or the minimum required to control the arrhythmia. Maintenance doses above 200mg daily should be managed by secondary care and are notpart of the SCP.